These updated guidelines are based on a first edition of the World Federation of Societies of
Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in …

Since the introduction of chlorpromazine and throughout the development of the new-
generation antipsychotic drugs (APDs) beginning with clozapine, the D 2 receptor has been …

Schizophrenia is characterized by positive, negative, cognitive, and affective symptoms.
Antipsychotic medications, which work by blocking the dopamine D 2 receptor, are the …

VIOLENCE IN SCHIZOPHRENIA AND BIPOLAR DISORDER Page 1 24 Psychiatria Danubina,
2013; Vol. 25, No. 1, pp 24-33 Review © Medicinska naklada - Zagreb, Croatia VIOLENCE IN …

Schizophrenia elevates the risk for aggressive behavior and violent crime, and different
approaches have been used to manage this problem. The results of such treatments vary …

Olanzapine is a second-generation atypical antipsychotic with proven efficacy for the
treatment of schizophrenia. Approved in 1996, olanzapine is one of the most studied …

The British Association for Psychopharmacology and the National Association of Psychiatric
Intensive Care and Low Secure Units developed this joint evidence-based consensus …

BACKGROUND: To optimize the management of patients with schizophrenia, quantification
of treatment effects is crucial. While in research studies, the use of quantitative assessments …

Schizophrenia affects various symptom domains, including positive and negative symptoms,
mood, and cognition. Cariprazine, a dopamine D 3/D 2 receptor partial agonist and …

Background In many countries of the industrialised world second generation ('atypical')
antipsychotics have become the first line drug treatment for people with schizophrenia. The …